Share on StockTwits

Stemcells (NASDAQ:STEM) is scheduled to post its quarterly earnings results on Tuesday, August 12th. Investors interested in registering for the company’s conference call can do so using this link.

Stemcells (NASDAQ:STEM) last announced its earnings results on Wednesday, May 14th. The company reported ($0.14) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.12) by $0.02. The company had revenue of $0.34 million for the quarter, compared to the consensus estimate of $0.24 million. During the same quarter last year, the company posted ($0.17) earnings per share. On average, analysts expect Stemcells to post $-0.59 EPS for the current fiscal year and $-0.54 EPS for the next fiscal year.

Stemcells (NASDAQ:STEM) opened at 1.65 on Monday. Stemcells has a one year low of $1.15 and a one year high of $2.43. The stock has a 50-day moving average of $1.87 and a 200-day moving average of $1.5. The company’s market cap is $91.6 million.

Several analysts have recently commented on the stock. Analysts at Brinson Patrick initiated coverage on shares of Stemcells in a research note on Wednesday, July 2nd. They set an “outperform” rating and a $7.00 price target on the stock. On the ratings front, analysts at Maxim Group raised their price target on shares of Stemcells from $2.50 to $5.00 in a research note on Friday, June 20th. They now have a “buy” rating on the stock. Finally, analysts at Chardan Capital reiterated a “positive” rating on shares of Stemcells in a research note on Tuesday, June 17th.

StemCells, Inc (NASDAQ:STEM) is engaged in the research, development, and commercialization of stem cell therapeutics and related enabling technologies for academia and industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.